Photo

Photo detail

Biolinq’s wearable glucose monitoring patch incorporates a microarray of independent electrochemical biosensors.

Stories this photo appears in:

Biolinq Raises $100 Million in Series B

HEALTHCARE: San Diego Co. Unveils Painless Glucose Sensor Patch

Biolinq, a medical device company developing a continuous glucose sensor with a novel integrated display on its wearable device, has closed a $100 million Series B financing round led by RiverVest Venture Partners.

Tease photo